Schlumberger
SLB

$48.83

1.35%

Market Cap: 69.8B

Energy Oil & Gas Field Services

0

Funds holding %

of 6,702 funds

0

Analysts bullish %

of 27 analysts

0

News positive %

of 44 articles

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

9% more repeat investments, than reductions

Existing positions increased: 588 | Existing positions reduced: 539

3% more capital invested

Capital invested by funds: $60.8B [Q4 2023] → $62.7B (+$1.92B) [Q1 2024]

1% less funds holding

Funds holding: 1,487 [Q4 2023] → 1,477 (-10) [Q1 2024]

6% less first-time investments, than exits

New positions opened: 147 | Existing positions closed: 157

3% less funds holding in top 10

Funds holding in top 10: 30 [Q4 2023] → 29 (-1) [Q1 2024]

4.2% less ownership

Funds ownership: 84.19% [Q4 2023] → 79.99% (-4.2%) [Q1 2024]

23% less call options, than puts

Call options by funds: $835M | Put options by funds: $1.08B

See Fund Rankings

Research analyst outlook

27 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target

$53

9%

upside

Avg. target

$67

37%

upside

High target

$77

58%

upside

27 analyst ratings

26 positive

96%

1 neutral

4%

0 negative

0%

Barclays David Anderson	37%upside $67	Overweight Maintained	23 Jul 2024
Evercore ISI Group James West	52%upside $74	Outperform Maintained	22 Jul 2024
TD Cowen Marc Bianchi	31%upside $64	Buy Maintained	22 Jul 2024
Benchmark Kurt Hallead	39%upside $68	Buy Reiterated	22 Jul 2024
RBC Capital Keith Mackey	41%upside $69	Outperform Reiterated	22 Jul 2024

See Analyst Rankings

Financial journalist opinion

Based on 44 articles about SLB published over the past 30 days

Zacks Investment Research

Schlumberger Limited (SLB) Is a Trending Stock: Facts to Know Before Betting on It

Schlumberger (SLB) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Schlumberger Limited (SLB) Is a Trending Stock: Facts to Know Before Betting on It

A.forall Announces the Launch of Their Fifth Abbreviated New Drug Application (ANDA) and Second “First Cycle” FDA Approval

MINNETONKA, Minn.--(BUSINESS WIRE)--A.forall's U.S. subsidiary Milla Pharmaceuticals Inc. announced the launch of the group's generic version of Precedex®, Dexmedetomidine Hydrochloride Injection 200 mcg per 50 mL and 400 mcg per 100 mL in 0.9% sodium chloride in glass bottles by its partner Sagent Pharmaceuticals. Dexmedetomidine Hydrochloride Injection is indicated for sedation of initially intubated and mechanically ventilated patients during treatment in an intensive care setting. Dexmedeto.

A.forall Announces the Launch of Their Fifth Abbreviated New Drug Application (ANDA) and Second “First Cycle” FDA Approval

SLB announces voluntary delisting from Euronext Paris

PARIS--(BUSINESS WIRE)--Regulatory News: SLB (NYSE: SLB) today announced that it will proceed with a voluntary delisting of its shares (ISIN: AN8068571086) from Euronext Paris. Consistent with its prior decisions to delist from other exchanges, SLB reviewed the low trading volumes on the Euronext Paris and, given the increasing costs, administrative requirements and managerial time required to maintain a dual listing, has requested a voluntary delisting from the Euronext Paris. SLB became a pub.

SLB announces voluntary delisting from Euronext Paris

SLB to Accelerate Co-Development of AI-Driven Digital Platform for Aker BP

HOUSTON--(BUSINESS WIRE)--Regulatory News: SLB and Aker BP today announced they have agreed a long-term partnership to co-develop an AI-driven digital platform for Aker BP to accelerate innovation and deliver substantial efficiency improvements across the company's E&P operations. The new platform will leverage the Delfi™ digital platform to enable new digital solutions in the cloud for Aker BP. “By co-developing AI-powered digital technologies, we will transform Aker BP's subsurface workfl.

SLB to Accelerate Co-Development of AI-Driven Digital Platform for Aker BP

24 Barron's Pro-Picked 2024 Mid-Year Dividend Dogs: Buy 2 In July

Barron's Mid-Year 2024 Pro Picks revealed by panelists for potential investment opportunities. Barron's interviews of eleven financial industry Roundtable-pros tapped 48 predictions. Twelve non-ADR foreign stocks and six funds were dropped by YCharts screens, and six selections paid no dividends, leaving 24 in the final pool. The Barron's list tracked by YCharts as of 7/17/24 projected ten top analyst-estimated net gains from WST, ASML, PBR, RUSHA & topped by SLB ranging 19.46%-35.09%.

24 Barron's Pro-Picked 2024 Mid-Year Dividend Dogs: Buy 2 In July

Ten Top Stocks That Can Hold Up No Matter Who Wins the Election

Investors should look for bargain quality stocks that can thrive regardless of political turmoil.

Ten Top Stocks That Can Hold Up No Matter Who Wins the Election

Zacks Investment Research

HAL & SLB: Comparative Financial Analysis of Q2 Earnings

Both Halliburton (HAL) and SLB (SLB) look forward to solid momentum in international markets during the second half of the year.

HAL & SLB: Comparative Financial Analysis of Q2 Earnings

Zacks Investment Research

Should Investors Steer Clear of SLB Stock After Q2 Earnings?

SLB recently reported strong Q2 earnings, but the North American rig count data indicates a bearish outlook for the business.

Should Investors Steer Clear of SLB Stock After Q2 Earnings?

3 Energy Stocks to Buy Now: Q3 Edition

The energy sector is one which is bound to grow over the next few years, meaning there are a good few energy stocks to buy now for the coming surge. We have tremendous needs, and these needs are only growing as we gain more and more electric technology.

3 Energy Stocks to Buy Now: Q3 Edition

SLB: The Market Doesn't Fully Appreciate The Growth Opportunities

SLB is not cheap but has been growing revenue and earnings at impressive rates. The market has been penalizing the company due to misunderstanding Saudi Arabia's shift from new offshore developments to the Jafurah unconventional gas field. SLB will benefit from the Saudi focus on Jafurah and the latest earnings report confirms the growth trend in the Middle East remains intact.

SLB: The Market Doesn't Fully Appreciate The Growth Opportunities

See News Rankings